🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
Connect with:
Monday / December 23. 2024

logo
mobile-logo
HomePosts Tagged "Pharmaceuticals"
Company News, People, World

Julio Triana is currently Head of Commercial Operations Region International for Bayer’s Pharmaceuticals Division

The Supervisory Board of Bayer AG has appointed Julio Triana to Bayer’s Board of Management effective April 1, 2024. He will become President of the Consumer Health Division effective May 1, 2024, and succeed Heiko Schipper, who has asked the Supervisory Board to bring forward the end date of his contract to pursue a career opportunity outside of Bayer. Schipper will leave the company effective April 30, 2024. 

Julio Triana is currently Head of Commercial Operations Region International for Bayer’s Pharmaceuticals Division, a member of the Division’s Executive Committee as well as the Senior Bayer Representative Japan and President of Bayer Holding, Ltd. Japan. Triana is a very seasoned executive with a dynamic 30-year career in the global healthcare industry. He joined Bayer in 2002 and has held roles of increasing responsibility in Finance, Strategy, Business Development and most recently Commercial Operations, among others. Triana holds an MBA from Universidad Antonio de Nebrija (Madrid, Spain) as well as a Bachelor of Science in Biology from the University of Houston (Houston, Texas, USA). He has comprehensive experience in leading and transforming large organizations across multiple functions and in different cultural contexts with a strong track record of successful market expansions, sustainable revenue growth and orchestrating complex integrations.

Julio Triana is currently Head of Commercial Operations

Award, Company News, World

The substrate offers high sensitivity, ranging from the nanogram down to the picogram level

Neogen Corporation announced that its K-Blue Luminescent ONE has won the 2023 Best Innovative Luminol-Based Substrate award at the International Life Sciences Awards 2023.

K-Blue Luminescent ONE, which was released in the U.S. and Canada in 2022, is an innovative, one-bottle chemiluminescent substrate designed to create a simpler workflow while minimising mixing errors and reducing plastic waste. The substrate offers high sensitivity, ranging from the nanogram down to the picogram level, and is optimised to emit light at 430 nanometers. It is now available in 35 countries worldwide.

“We are honoured to have received this award and demonstrate our unwavering commitment to providing innovative and high-quality substrates to diagnostic kit manufacturers,” said John Adent, Neogen’s President and Chief Executive Officer. “Neogen’s certified quality management system, which oversees all aspects of the development and manufacturing processes, has helped K-Blue Luminescent ONE earn a reputation for providing consistent, high-quality results. We are proud to provide novel solutions that our customers can trust.”

The International Life Science Awards is an annual recognition event organised by Global Health & Pharma Magazine. These awards highlight and celebrate organisations and individuals who have made significant contributions to the field of life sciences on an international level. The awards typically cover various categories within the life sciences sector, including biotechnology, pharmaceuticals, medical research, healthcare solutions, and more.

With over 30 years of experience developing and manufacturing ELISA test kits, substrates, and reagents, Neogen provides the support and products that enable dependable and reliable results, including an extensive line of forensic and research ELISA test kits, substrates, and reagents for immunoassay applications, testing equipment packages, and experienced technical support.

The substrate offers high sensitivity, ranging from

AgroPolicy

A pre-event summit has been organised by the Health & Family Welfare Department, Government of Gujarat, with a theme “Holistic Healthcare focused on Pharmaceuticals and Medical Devices” on December 18, 2021

The Government of Gujarat is organising the 10th Vibrant Gujarat Global Summit 2022, from January 10 -12, 2022, at Mahatma Mandir Convention and Exhibition Centre, Gandhinagar, Gujarat. A pre-event summit has been organised by the Health & Family Welfare Department, Government of Gujarat, with a theme “Holistic Healthcare focused on Pharmaceuticals and Medical Devices” on December 18, 2021, in Pandit Deendayal Energy University, Gandhinagar, Gujarat.

The pre-event summit was inaugurated by Mansukh Mandaviya, Union Minister for Health & Family Welfare and Chemicals & Fertilisers and Bhupendra Patel, Chief Minister of Gujarat. S Aparna, IAS, Secretary, Department of Pharmaceuticals, Government of India, Dr Sarah Mcmullen, India Office Country Director, United States Food and Drug Control Administration (US FDA) and Dr V G Somani, Drugs Controller General of India were also present on the occasion.

The pre-event summit focused on the following:

  • Boosting Bulk Drug Production through Production Linked Incentive (PLI) Scheme
  • Reducing India’s Dependence in Active Pharmaceutical Ingredients (APIs) & Medical Devices
  • Jan Aushadhi Kendras – Generic Medicines

During the summit, Mansukh Mandaviya, inaugurated the stall of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Through the PMBJP stall, PMBI informed the salient features of PMBJP and benefits of Jan Aushadhi Generic Medicines which are available at affordable prices through more than 8500 Pradhan Mantri Bhartiya Janaushadhi Kendras, functioning across the country.

During this pre-event summit, technical sessions covered various aspects of the Production Linked Incentive (PLI) Scheme and the opportunities to enhance bulk drug production.

A pre-event summit has been organised by